Pulmonary diseases pose an immense threat to global health. Several nanotherapeutics- based approaches aimed to tackle pulmonary ailments in recent years. The current …
The rise of tuberculosis (TB) superbugs has impeded efforts to control this infectious ailment, and new treatment options are few. Paradoxical Inflammation (PI) is another major problem …
Central nervous system tuberculosis (CNS-TB) is the most severe extra-pulmonary manifestation of tuberculosis (TB), facing significant challenges due to the limited …
Central nervous system tuberculosis (CNS-TB) is a severe form of extra-pulmonary tuberculosis with high mortality and morbidity rates. The standard treatment regimen for CNS …
Obesity is a metabolic disease, which is one of the major causes of morbidity and mortality, where therapeutic options are limited. Treatment of obesity is necessary as it is associated …
Background Vildagliptin (VLG), an antidiabetic agent, presents a potential solution to this widespread affliction. It exhibits notable attributes, such as a high solubility and a shorter …
In the last decade, nanocarriers have been widely used to target specific organs and disorders of any kind. Nonetheless, the commercialization of nanocarriers for many …
E Ray, K Jadhav, M Kadian, G Sharma… - Journal of Materials …, 2024 - pubs.rsc.org
Lung cancer is one of the most fatal malignancies, with the highest death rate (∼ 19%), and the NSCLC type accounts for∼ 85% of lung cancers. In the search for new treatments …
E Ray, K Jadhav, M Kadian, G Sharma… - International Journal of …, 2024 - Elsevier
Lung carcinoma, particularly non-small-cell lung cancer (NSCLC), accounts for a significant portion of cancer-related deaths, with a fatality rate of approximately 19%. Niclosamide …